National and Kapodistrian University of Athens
Αξιολόγηση της χορήγησης σημασμένου με LU-177 DOTATATE μετά από καθετηριασμό της ηπατικής αρτηρίας σε νευροενδοκρινούς χαρακτήρα ηπατικές μεταστάσεις
Abstract
dc:descriptionPurpose: The aim of this study is to evaluate the effectiveness of Lu-177-DOTA-TATE infusions after selective catheterization of the hepatic artery in inoperable liver metastasized sst2 receptor-positive neuroendo-crine tumours due to the effect of β- emission, minimising in parallel the toxicity of non-target tissue. Methods: The average dose per session administered monthly to each patient (14 cases in total) was 6.3±2.3 GBq. Repetitions did not exceed 6-fold. Response assessment was classified according to the RECIST criteria. CT/ MRI scans were performed before and after the end of treatment; monthly ultrasound scans were performed for follow-up. Toxicity (WHO criteria) was measured using blood and urine tests for renal, hepatic and bone marrow function.Results: Νone patient has achieved complete response [CR], partial response[PR] was shown in 9/14 (65%), and disease stabilization[SD] in 2/14 (14%) patients; three patients (21.0%) did not respond [PD]. Grade 1 myelotoxicity occurred in 8 cases, grade 2-3 in 4 and grade 4 in 2 (blood transfusion). Conclusion: In unresectable metastatic liver lesions, positive for somatostatin receptors repeated, trans-hepatic infusions of Lu-177-DOTA-TATE showed an effective therapeutic outcome. No nephro- or liver- toxicity has so far been observed. Myelo- toxicity was appro-priately managed.
Degree
thesis:*- Grantor dc:publisher
- National and Kapodistrian University of Athens
- Year dc:date
- 2016
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Poulantzas, Vasileios
- Πουλαντζάς, Βασίλειος
Subjects
dc:subject × 7Rights
dc:rights- Statement dc:rights
-
- BY
- Language dc:language
- gre
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/38160